Cyp46 polymorphisms in Alzheimer's disease: a review.
Increasing research findings argue for a link between brain cholesterol turnover and Alzheimer's disease (AD). High cerebral levels of this lipid increase Ass load. The elimination of cerebral cholesterol involves two mechanisms, dependent of apolipoprotein E and cholesterol 24-hydroxylase (CYP46). CYP46 is a gene associated with AD; the most studied single nucleotide polymorphism is the rs754203, which changes T-->C. Some studies describe that this polymorphism is possibly associated with loss of function of CYP46; others describe that it is possibly associated with cerebral cholesterol accumulation or an increase of CYP46 activity leading to an accumulation of the 24S-hydroxycholesterol in cerebrospinal fluid. Publications about this subject around the world are controversial. Some studies associate the T allele with AD and others the C allele. The aim of this review is to describe and summarize the findings of the researches about the relationship between CYP46 and AD that have been published in the past 9 years.
Garcia
Anália Nusya Medeiros
AN
Instituto de Ciências Biológicas, UPE, Recife, Brazil.
Muniz
Maria Tereza Cartaxo
MT
Souza e Silva
Hugo Rafael
HR
da Silva
Helker Albuquerque
HA
Athayde-Junior
Luiz
L
D000544:Alzheimer Disease / Q000134:cerebrospinal fluid* / Q000235:genetics* / Q000503:physiopathology; D016229:Amyloid beta-Peptides / Q000378:metabolism; D001483:Base Sequence / Q000235:genetics; D001921:Brain / Q000378:metabolism / Q000503:physiopathology; D001923:Brain Chemistry / Q000235:genetics; D002784:Cholesterol / Q000378:metabolism*; D000072556:Cholesterol 24-Hydroxylase; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D011110:Polymorphism, Genetic / Q000235:genetics*; D013250:Steroid Hydroxylases / Q000235:genetics* / Q000378:metabolism*
D016229:Amyloid beta-Peptides; D005819:Genetic Markers; D002784:Cholesterol; D013250:Steroid Hydroxylases; D000072556:Cholesterol 24-Hydroxylase
Neurosci Lett. 2004 Sep 2;367(2):228-31
15331159
Biochim Biophys Acta. 2003 Mar 10;1610(2):281-90
12648781
Dement Geriatr Cogn Disord. 2004;18(3-4):257-60
15286456
Dement Geriatr Cogn Disord. 2006;22(5-6):399-404
16960449
Brain Res. 2007 May 25;1147:34-8
17335784
J Neurochem. 1995 Feb;64(2):895-901
7830084
J Lipid Res. 1998 Aug;39(8):1594-600
9717719
J Alzheimers Dis. 2009;17(2):359-68
19363267
Hum Genet. 2004 May;114(6):581-7
15034781
J Nutr Health Aging. 2003;7(1):37-41
12679839
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2070-5
14970312
Int Psychogeriatr. 2006 Mar;18(1):37-45
16734927
J Psychiatr Res. 2002 Jan-Feb;36(1):27-32
11755458
BMJ. 2001 Jun 16;322(7300):1447-51
11408299
J Neurochem. 1991 Jun;56(6):2082-6
2027015
J Neurol Neurosurg Psychiatry. 2006 Mar;77(3):421-2
16484661
Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7238-43
10377398
Arch Neurol. 2003 Jan;60(1):16-8
12533083
Neurosci Lett. 2002 Aug 2;328(1):9-12
12123847
Eur J Pharmacol. 2001 Jan 19;412(1):1-12
11166730
Dement Geriatr Cogn Disord. 2006;21(2):81-7
16340204
Neurochem Res. 2005 Aug;30(8):943-8
16258842
Neurosci Lett. 2001 Nov 13;314(1-2):45-8
11698143
Mol Psychiatry. 2002;7(8):899-902
12232784
Neurosci Lett. 2004 Jun 10;363(2):139-43
15172102
Int J Geriatr Psychiatry. 2009 Sep;24(9):921-6
19212968
Neurosci Lett. 2005 Jul 22-29;383(1-2):105-8
15936520
Neuroreport. 2004 Jan 19;15(1):95-8
15106838
Neurosci Lett. 2004 Oct 14;369(2):104-7
15450677
Neurobiol Aging. 2006 May;27(5):773.e1-773.e3
16055229
Neuroepidemiology. 1998;17(1):14-20
9549720
Arch Neurol. 2003 Jan;60(1):29-35
12533085
Eur Psychiatry. 2009 Apr;24(3):183-90
19286353
Neurobiol Aging. 2004 Jul;25(6):747-51
15165699